Mark Lawler, Associate Director of Postgraduate Studies, Chair in Translational Cancer Genomics, and Professor of Digital Health at Queen’s University Belfast, shared a post on LinkedIn:
“Great start to our event here in Brussels with Francesco Pignatti giving the opening keynote at The Cancer Drug Development Forum (CDDF) AAADV Workshop joint event.
Critical that we work together across the pond, particularly in these challenging times. Always love listening to Francesco as he delivers such thoughtful interventions.
The focus on patients evident from the very start, with Francesco highlighting nearly 25 years ago how Kathy Oliver patient advocate extraordinaire and wonderful colleague indicated to him the need to be collecting patient data. Kathy – prescient as usual, predated what we now call Patient Reported Outcomes (PROs) by nearly a quarter of a century.
So when patients talk – please listen, but don’t just listen, Act! ”
Other Articles Featuring Mark Lawler on OncoDaily.